Charlton Aria Acquisition
CHARR · NASDAQ
CHARR key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 89.35K
- Volume
- 679
- Open price
- $0.1802
- High today
- $0.1672
- Low today
- $0.1583
- 52 Week high
- $0.26
- 52 Week low
- $0.0331
Charlton Aria Acquisition (CHARR) at a glance
As of Oct 27, 2026, Charlton Aria Acquisition (CHARR) shares are priced at $0.1583, giving the company a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.1583 and $0.1672. The current price is 0.0% above the day's low and 5.3% below its high.
Volume so far is 679 shares, below the average of 89.35K shares a day.
Over the past year Charlton Aria Acquisition has ranged from $0.0331 to $0.26, and now sits 55% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- RDARRaadr$0.0002−16.67%
- AXGSolowin Holdings$0.04−25.65%
- AEFIAmerican EcoFuels$0.0009+12.50%
- SHFSSHF Holdings$0.1158+23.19%
- DVLTDatavault AI$0.067−49.55%
- MASNMaison Luxe$0.0002+0.00%
- XXII22nd Century Group$0.1048+18.55%
- NBNDNetBrands$0.0007+0.00%
- NEXRNexera Technologies$0.5454+21.77%
- TIPSTianrong Internet Products & Services$0.0011+57.14%
- AITXArtificial Intelligence Technology Solutions$0.0008−20.00%
Newly listed
Companies that went public in the past six weeks
- LYCALycia Therapeutics$26.11−9.50%
- DAVIDAVION HEALTHCARE$3.00−26.29%
- TCXBTCGX Acquisition Corp. II$10.28+0.10%
- CTYCITY THERAPEUTICS$20.86+0.34%
- IAMIambic Therapeutics$14.00−2.85%
- AMROAmaero$6.04+12.48%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.23−0.49%
- TRXBTRex Bio$13.79−0.58%
- RTSNRetension Pharmaceuticals$13.52−5.06%
- PAXGUPine Tree Acquisition$10.00−0.20%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.20+1.36%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.